The stepped wedge cluster randomised trial: what it is and when it should be used
نویسندگان
چکیده
منابع مشابه
Tigecycline: what is it, and where should it be used?
Tigecycline is the first glycylcycline to be launched and is one of the very few new antimicrobials with activity against Gram-negative bacteria. It evades acquired efflux and target-mediated resistance to classical tetracyclines, but not chromosomal efflux in Proteeae and Pseudomonas. Cmax+ is low, but tissue penetration is excellent and the compound has shown equivalence to imipenem/cilastati...
متن کاملArtificial Intelligence: What It Is, and What It Should Be
What Artificial Intelligence (AI) is at the current time is not what it should be. The mainstream works in the field are on domain-specific problems and solutions. Instead, AI should focus on general-purpose systems that are adaptive to its environment, and can work with insufficient knowledge and resources. AI in this sense is unified with Cognitive Science at a general level, with the latter ...
متن کاملCorporate Democracy – What It Is, What It Isn’t, and What It Should Be
2 See, e.g., Stephen Deane, The ISS Institute for Corporate Governance, Majority Voting in Director Elections: From the Symbolic to the Democratic, at 1 (noting that advocates who favor majority voting in director elections view the issue as a “question of democratic principle” and, if implemented, majority voting “would transform the current symbolic process, in which shareholders can withhold...
متن کاملStepped-wedge cluster randomised trials: where, when and why?
The stepped wedge (SW) cluster randomised trial (CRT) design is being utilised at increasing pace. However, little is known about the standard of reporting of such trials, or how useful the design has proven to be in hindsight. Moreover, much debate exists around when the design should be preferred to the more classical parallel group (PG) CRT. Here, we address these issues by first conducting ...
متن کاملComponent resolved diagnosis: when should it be used?
The knowledge on molecular allergy diagnosis is continuously evolving. It is now time for the clinician to integrate this knowledge and use it when needed to improve the accuracy of diagnosis and thus provide more precise therapeutic and avoidance measures. This review does not intend to comprehensively analyze all the available allergen molecules, but to provide some practical clues on use and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Journal of Australia
سال: 2019
ISSN: 0025-729X,1326-5377
DOI: 10.5694/mja2.50018